Balyasny Asset Management
ARGS

Balyasny Asset Management’s Argos Therapeutics, Inc. ARGS Stock Holding History

Balyasny Asset Management’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-15,350
Closed -$14K – 2139
2018
Q1 		$14K Buy
+15,350
New +$14K ﹤0.01% 1691